POST Online Media Lite Edition


LabConnect appoints chief operating officer

Staff writer |
Seattle, Wa., USA - August 25, 2009, Seattle, Wa., USA - LabConnect, LLC, a provider of central laboratory services to the biopharmaceutical industry, announced the appointment of Frank D. Morrow as its chief operating officer.

Article continues below

Dr. Morrow is a veteran of the central lab business, having served as founding executive, president and chief scientific officer at Quintiles Laboratories Worldwide, where he was responsible for the division's growth from inception to $120M in revenue, 1,000 employees, and five wholly owned central laboratory facilities worldwide over ten years. Subsequent to Quintiles, he served as Vice President, Worldwide Operations, at Quest Diagnostics Clinical Trials.

Dr. Morrow has his clinical laboratory directorship license in more than ten states, a doctorate in clinical biochemistry from the University of Georgia, and a master's degree in human physiology from Pennsylvania State University. Dr. Morrow completed post-doctoral studies at the Harvard School of Public Health in Boston before becoming Director of the Nutrition Evaluation Laboratory of the USDA Human Nutrition Research Center on Aging at Tufts University and an adjunct assistant professor of nutrition at Tufts School of Human Nutrition.


What to read next

ISS appoints COO for the Americas & Asia Pacific
Blackstone: Marc Bolland head of European portfolio operations
LafargeHolcim appoints Ron Wirahadiraksa as CFO